Lawmakers ask FDA for timeline on reclassifying hydrocodone

02/17/2013 | Hill, The · Pharmalot.com

Seven U.S. lawmakers asked the FDA to create a time frame for reclassifying hydrocodone drugs from Schedule III to Schedule II. The change would mean patients would need a physician's written prescription to be able to purchase the medications.

View Full Article in:

Hill, The · Pharmalot.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC